Orser Capital Management, LLC Bristol Myers Squibb CO Transaction History

Orser Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $53,630 - $62,520	-1,000 Reduced 19.88%	4,030 $251,000
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $12,382 - $13,484	200 Added 4.14%	5,030 $336,000
Q2 2020 Jul 29, 2020	SELL	$54.82 - $64.09 $9,867 - $11,536	-180 Reduced 3.59%	4,830 $284,000
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $108,754 - $141,859	2,210 Added 78.93%	5,010 $319,000
Q2 2019 Sep 20, 2019	SELL	$44.62 - $49.34 $98,610 - $109,041	-2,210 Reduced 44.11%	2,800 $227,000
Q1 2019 Nov 14, 2019	SELL	$45.12 - $53.8 $1.48 Million - $1.76 Million	-32,720 Reduced 86.72%	5,010 $239,000
Q3 2018 Nov 20, 2019	SELL	$55.19 - $62.25 $59,053 - $66,607	-1,070 Reduced 2.76%	37,730 $2.11 Million
Q2 2018 Nov 14, 2019	SELL	$50.53 - $62.98 $111,671 - $139,185	-2,210 Reduced 5.39%	38,800 $2.2 Million
Q1 2018 Nov 14, 2019	BUY	$59.92 - $68.98 $2.46 Million - $2.83 Million	41,010 New	41,010 $2.11 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Orser Capital Management, LLC with notifications on news.